China’s Jiuyuan Genetic Applies for Approval for Wegovy Biosimilar
February 26, 2026 — 16:05 CST
This Data Is Locked!
This area is available only to Subscribers.
China-based Jiuyuan Genetic has submitted a request seeking approval for a biosimilar version of Wegovy, a significant advancement in the pharmaceutical sector. The application for... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
